Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1990 1
1993 1
1994 1
1998 2
2000 1
2002 2
2003 1
2004 2
2005 3
2006 4
2007 1
2008 5
2009 6
2010 4
2011 15
2012 17
2013 13
2014 8
2015 10
2016 14
2017 15
2018 28
2019 53
2020 74
2021 102
2022 113
2023 120
2024 51

Text availability

Article attribute

Article type

Publication date

Search Results

570 results

Results by year

Filters applied: . Clear all
Page 1
Evaluating cannabidiol (CBD) expectancy effects on acute stress and anxiety in healthy adults: a randomized crossover study.
Spinella TC, Stewart SH, Naugler J, Yakovenko I, Barrett SP. Spinella TC, et al. Psychopharmacology (Berl). 2021 Jul;238(7):1965-1977. doi: 10.1007/s00213-021-05823-w. Epub 2021 Apr 4. Psychopharmacology (Berl). 2021. PMID: 33813611 Free PMC article. Clinical Trial.
OBJECTIVES: We evaluated whether CBD expectancy alone could influence stress, anxiety, and mood, and the extent to which beliefs regarding CBD effects predicted these responses. ...Overall, there were no systematic changes in subjective stress, or anxiety
OBJECTIVES: We evaluated whether CBD expectancy alone could influence stress, anxiety, and mood, and the extent to which belie …
Cannabidiol as a Potential Treatment for Anxiety Disorders.
Blessing EM, Steenkamp MM, Manzanares J, Marmar CR. Blessing EM, et al. Neurotherapeutics. 2015 Oct;12(4):825-36. doi: 10.1007/s13311-015-0387-1. Neurotherapeutics. 2015. PMID: 26341731 Free PMC article. Review.
The purpose of the current review is to determine CBD's potential as a treatment for anxiety-related disorders, by assessing evidence from preclinical, human experimental, clinical, and epidemiological studies. We found that existing preclinical evidence strongly su …
The purpose of the current review is to determine CBD's potential as a treatment for anxiety-related disorders, by assessing e …
Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report.
Crippa JA, Derenusson GN, Ferrari TB, Wichert-Ana L, Duran FL, Martin-Santos R, Simões MV, Bhattacharyya S, Fusar-Poli P, Atakan Z, Santos Filho A, Freitas-Ferrari MC, McGuire PK, Zuardi AW, Busatto GF, Hallak JE. Crippa JA, et al. J Psychopharmacol. 2011 Jan;25(1):121-30. doi: 10.1177/0269881110379283. Epub 2010 Sep 9. J Psychopharmacol. 2011. PMID: 20829306 Clinical Trial.
Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. ...These results suggest that CBD reduces anxiety in SAD and that this is related to its effects on activity in limbic and paralimbic brain a …
Animal and human studies indicate that cannabidiol (CBD), a major constituent of cannabis, has anxiolytic properties. ...These result …
Cannabidiol in Anxiety and Sleep: A Large Case Series.
Shannon S, Lewis N, Lee H, Hughes S. Shannon S, et al. Perm J. 2019;23:18-041. doi: 10.7812/TPP/18-041. Perm J. 2019. PMID: 30624194 Free PMC article.
OBJECTIVE: To determine whether CBD helps improve sleep and/or anxiety in a clinical population. ...The retrospective chart review included monthly documentation of anxiety and sleep quality in 103 adult patients. MAIN OUTCOME MEASURES: Sleep and anxiety
OBJECTIVE: To determine whether CBD helps improve sleep and/or anxiety in a clinical population. ...The retrospective chart re …
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders.
García-Gutiérrez MS, Navarrete F, Gasparyan A, Austrich-Olivares A, Sala F, Manzanares J. García-Gutiérrez MS, et al. Biomolecules. 2020 Nov 19;10(11):1575. doi: 10.3390/biom10111575. Biomolecules. 2020. PMID: 33228239 Free PMC article. Review.
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD displays an interesting pharmacological profile without the potential for becoming a drug of abuse, unlike THC. In this review, we focused …
Numerous studies have been carried out using the main phytocannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). CBD
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD).
Peng J, Fan M, An C, Ni F, Huang W, Luo J. Peng J, et al. Basic Clin Pharmacol Toxicol. 2022 Apr;130(4):439-456. doi: 10.1111/bcpt.13710. Epub 2022 Feb 6. Basic Clin Pharmacol Toxicol. 2022. PMID: 35083862 Free article. Review.
CBD could also be applied to treat or prevent COVID-19 and its complications. Here, we provide a narrative review of CBD's applications in human diseases: from mechanism of action to clinical trials....
CBD could also be applied to treat or prevent COVID-19 and its complications. Here, we provide a narrative review of CBD's app
A Review of Human Studies Assessing Cannabidiol's (CBD) Therapeutic Actions and Potential.
White CM. White CM. J Clin Pharmacol. 2019 Jul;59(7):923-934. doi: 10.1002/jcph.1387. Epub 2019 Feb 7. J Clin Pharmacol. 2019. PMID: 30730563 Review.
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures is a clear exception, with strong evidence of CBD's benefit. Acute CBD dosing before anxiety-provoking events like publ …
Cannabidiol (CBD) is a highly touted product for many different disorders among the lay press. ...The control of refractory seizures …
Use of cannabidiol in anxiety and anxiety-related disorders.
Skelley JW, Deas CM, Curren Z, Ennis J. Skelley JW, et al. J Am Pharm Assoc (2003). 2020 Jan-Feb;60(1):253-261. doi: 10.1016/j.japh.2019.11.008. Epub 2019 Dec 19. J Am Pharm Assoc (2003). 2020. PMID: 31866386
OBJECTIVE: Cannabidiol (CBD) has a proposed novel role in the management of anxiety owing to its actions on the endocannabinoid system. ...CONCLUSION: CBD has a promising role as alternative therapy in the management of anxiety disorders. ...
OBJECTIVE: Cannabidiol (CBD) has a proposed novel role in the management of anxiety owing to its actions on the endocannabinoi …
COVID-19 and Cannabidiol (CBD).
Khalsa JH, Bunt G, Maggirwar SB, Kottilil S. Khalsa JH, et al. J Addict Med. 2021 Sep-Oct 01;15(5):355-356. doi: 10.1097/ADM.0000000000000771. J Addict Med. 2021. PMID: 33323690 Free PMC article. Clinical Trial.
Cannabis products such as cannabidiol (CBD) are being advertised for the treatment of COVID-19 associated mental health problems and substance use disorders. This commentary will briefly clear the myth that CBD can ameliorate a wide range of COVID-19 associated heal …
Cannabis products such as cannabidiol (CBD) are being advertised for the treatment of COVID-19 associated mental health problems and …
THC and CBD: Villain versus Hero? Insights into Adolescent Exposure.
Pintori N, Caria F, De Luca MA, Miliano C. Pintori N, et al. Int J Mol Sci. 2023 Mar 9;24(6):5251. doi: 10.3390/ijms24065251. Int J Mol Sci. 2023. PMID: 36982327 Free PMC article. Review.
By binding to the same receptors, THC is psychoactive, while CBD has anxiolytic and antipsychotic properties. Lately, a variety of hemp-based products, including CBD and THC, have become widely available in the food and health industry, and medical and recreational …
By binding to the same receptors, THC is psychoactive, while CBD has anxiolytic and antipsychotic properties. Lately, a variety of he …
570 results